Home > Insider Trading > Filing (0000950103-23-011942)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1356090	Precigen Inc.	PGEN	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1724195	Helen Sabzevari	20374 Seneca Meadows Parkway Germantown MD 20876	President And Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2023-08-09	141,587	$0.00	1,451,090	No	4	M	Direct
Common Stock	Disposition	2023-08-11	41,436	$1.44	1,409,654	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Restricted Stock Units	Disposition	2023-08-09	141,587	$0.00	141,587	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
283,173			No	4	M	Direct

Footnotes

Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock.
Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs pursuant to the terms of a 10b5-1 plan adopted by the reporting person. The sale was effected through an automatic "sell to cover" transaction that did not represent a discretionary trade by the reporting person.
Represents 1/6 of the RSUs granted on March 24, 2023 that vested on August 9, 2023. The remaining RSUs vest in two equal installments on each of August 16, 2023 and August 23, 2023.